Vigil Neuroscience Valuation
| VIGL Stock | USD 1.89 0.05 2.72% |
Based on Macroaxis valuation methodology, the company appears to be overvalued. Vigil Neuroscience has a current Real Value of $1.73 per share. The regular price of the company is $1.89. Our model measures the value of Vigil Neuroscience from inspecting the company fundamentals such as Shares Outstanding of 46.67 M, return on equity of -0.9, and Shares Owned By Institutions of 68.24 % as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Vigil Neuroscience's valuation include:
Overvalued
Today
Please note that Vigil Neuroscience's price fluctuation is dangerous at this time. Calculation of the real value of Vigil Neuroscience is based on 3 months time horizon. Increasing Vigil Neuroscience's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Vigil stock is determined by what a typical buyer is willing to pay for full or partial control of Vigil Neuroscience. Since Vigil Neuroscience is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Vigil Stock. However, Vigil Neuroscience's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.89 | Real 1.73 | Target 16.19 | Hype 1.84 | Naive 1.89 |
The intrinsic value of Vigil Neuroscience's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Vigil Neuroscience's stock price.
Estimating the potential upside or downside of Vigil Neuroscience helps investors to forecast how Vigil stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Vigil Neuroscience more accurately as focusing exclusively on Vigil Neuroscience's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Vigil Neuroscience's intrinsic value based on its ongoing forecasts of Vigil Neuroscience's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Vigil Neuroscience's closest peers.
Vigil Neuroscience Cash |
|
Vigil Valuation Trend
Knowing Vigil Neuroscience's actual value is paramount for traders when making sound investment determinations. Using both Vigil Neuroscience's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Vigil Neuroscience Total Value Analysis
Vigil Neuroscience is at this time forecasted to have valuation of 5.23 M with market capitalization of 85.88 M, debt of 12.95 M, and cash on hands of 148.91 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Vigil Neuroscience fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.23 M | 85.88 M | 12.95 M | 148.91 M |
Vigil Neuroscience Asset Utilization
One of the ways to look at asset utilization of Vigil is to check how much profit was generated for every dollar of assets it reports. Vigil Neuroscience has a negative utilization of assets of -0.43 %, losing $0.004336 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Vigil Neuroscience shows how discouraging it operates for each dollar spent on its assets.Vigil Neuroscience Ownership Allocation
Vigil Neuroscience shows a total of 46.67 Million outstanding shares. Over half of Vigil Neuroscience's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Vigil Neuroscience Profitability Analysis
Net Loss for the year was (84.26 M) with profit before overhead, payroll, taxes, and interest of 0.About Vigil Neuroscience Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Vigil Neuroscience. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Vigil Neuroscience based exclusively on its fundamental and basic technical indicators. By analyzing Vigil Neuroscience's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Vigil Neuroscience's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Vigil Neuroscience. We calculate exposure to Vigil Neuroscience's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Vigil Neuroscience's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -359.1 K | -377.1 K |
Vigil Neuroscience Growth Indicators
Investing in growth stocks can be very risky. If the company such as Vigil Neuroscience does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 40.7 M |
Vigil Neuroscience Current Valuation Indicators
Vigil Neuroscience's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Vigil Neuroscience's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Vigil Neuroscience, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Vigil Neuroscience's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Vigil Neuroscience's worth.When determining whether Vigil Neuroscience is a strong investment it is important to analyze Vigil Neuroscience's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vigil Neuroscience's future performance. For an informed investment choice regarding Vigil Stock, refer to the following important reports: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vigil Neuroscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more information on how to buy Vigil Stock please use our How to buy in Vigil Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vigil Neuroscience. If investors know Vigil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vigil Neuroscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Vigil Neuroscience is measured differently than its book value, which is the value of Vigil that is recorded on the company's balance sheet. Investors also form their own opinion of Vigil Neuroscience's value that differs from its market value or its book value, called intrinsic value, which is Vigil Neuroscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vigil Neuroscience's market value can be influenced by many factors that don't directly affect Vigil Neuroscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vigil Neuroscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vigil Neuroscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vigil Neuroscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.